Anika Therapeutics Inc · Healthcare · Medical Equipment
As of 2026-06-26, Anika Therapeutics Inc (ANIK) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.8%, relative volume 2.34×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
45 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ANIK is in a stage 2 uptrend, week 1. Currently in a 48-day base; basing ADR 4.5% (broad 3.9%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 2.1% / 28.8%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ANIK is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $6M notional. Top 3 carry $13M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $6M |
| IWMiShares Russell 2000 ETF | 0.01% | $4M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ANIK Jan avg: 2.06% median: 3.72% win: 75% σ: 4.04% n: 4 2022-04-12 → 2026-05-29 | ANIK Feb avg: 15.83% median: 2.76% win: 100% σ: 26.50% n: 4 2022-04-12 → 2026-05-29 | ANIK Mar avg: -4.42% median: -4.21% win: 50% σ: 8.66% n: 4 2022-04-12 → 2026-05-29 | ANIK Apr avg: -7.24% median: -10.03% win: 20% σ: 6.45% n: 5 2022-04-12 → 2026-05-29 | ANIK May avg: -0.19% median: 0.97% win: 60% σ: 14.60% n: 5 2022-04-12 → 2026-05-29 | ANIK Jun avg: -1.95% median: -2.67% win: 25% σ: 3.48% n: 4 2022-04-12 → 2026-05-29 (current) | ANIK Jul avg: -4.98% median: -2.77% win: 50% σ: 13.74% n: 4 2022-04-12 → 2026-05-29 | ANIK Aug avg: -4.70% median: -4.47% win: 25% σ: 15.19% n: 4 2022-04-12 → 2026-05-29 | ANIK Sep avg: 1.50% median: 2.29% win: 75% σ: 4.22% n: 4 2022-04-12 → 2026-05-29 | ANIK Oct avg: -0.73% median: 4.20% win: 75% σ: 21.25% n: 4 2022-04-12 → 2026-05-29 | ANIK Nov avg: 7.06% median: 7.27% win: 100% σ: 5.43% n: 4 2022-04-12 → 2026-05-29 | ANIK Dec avg: -3.14% median: -4.44% win: 25% σ: 4.76% n: 4 2022-04-12 → 2026-05-29 |